Discovery & Development COVID-19, Contract Development Services, Contract Manufacturing Services

Post-Pandemic Planning: What Will Change in Early-Phase Drug Development?

Join Thermo Fisher Scientific’s drug development and manufacturing experts for a unique, extended Q&A session and learn how to start navigating the new normal.

06/30/2020

sponsored by Thermo Fisher Scientific

Available On-Demand

June 30th, 2020, 11am EDT

Even as governments around the world begin to re-open, COVID-19 will have a lasting impact on how the pharmaceutical industry functions both in the immediate future and long-term. The development, trial and manufacture of medications will drastically change as sponsors find new ways to interact with both contract manufacturing organizations and patients. How can you navigate this unprecedented environment while still meeting milestones? Join Thermo Fisher Scientific’s drug development and manufacturing experts for a unique, extended Q&A session and learn how to start navigating the new normal.

Key Learning Objectives:

The impact of COVID-19 on sponsor/CDMO relationships moving forward
How Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs
Answers to your questions surrounding the new post-pandemic landscape

Available On-Demand

Visit our Webinar Hub

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.